Literature DB >> 22843908

Definitive radiation therapy for extramammary Paget's disease.

Masaharu Hata1, Izumi Koike, Hidefumi Wada, Etsuko Miyagi, Kazumasa Odagiri, Yumiko Minagawa, Takeo Kasuya, Hisashi Kaizu, Tomio Inoue.   

Abstract

BACKGROUND: Extramammary Paget's disease (EMPD) is frequently inoperable because of old age and/or coexisting disease. We therefore reviewed the efficacy and toxicity of radiation therapy for EMPD. PATIENTS AND METHODS: Fourteen patients with EMPD underwent definitive radiation therapy. Three patients had regional lymph node metastases before radiation therapy, but none had distant metastasis. Total doses of 52-80.2 Gy (median=60.6 Gy) were delivered to tumor sites in 26-43 fractions (median=33 fractions).
RESULTS: Four patients had developed recurrence at a median follow-up period of 47 months. The 5-year local control and disease-free rates were 71% and 63%, respectively. Two patients died of old age and renal failure at 6 and 51 months, respectively, after irradiation. The 5-year disease-free, cause-specific and overall survival rates were 46%, 100% and 79%, respectively. No therapy-related toxicities of grade 3 or greater were observed.
CONCLUSION: Radiation therapy is effective and safe, and appears to offer a curative treatment option for patients with EMPD.

Entities:  

Mesh:

Year:  2012        PMID: 22843908

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  1 in total

Review 1.  Primary extramammary invasive Paget's vulvar disease: what is the standard, what are the challenges and what is the future for radiotherapy?

Authors:  Maria Tolia; Nikolaos Tsoukalas; Chrisostomos Sofoudis; Constantinos Giaginis; Despoina Spyropoulou; Dimitrios Kardamakis; Vasileios Kouloulias; George Kyrgias
Journal:  BMC Cancer       Date:  2016-07-29       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.